Letters
NICE on non-alcoholic fatty liver disease (NAFLD)
Authors’ reply to Tavabie
BMJ 2016; 355 doi: https://doi.org/10.1136/bmj.i5436 (Published 11 October 2016) Cite this as: BMJ 2016;355:i5436
- Chris Day, professor of liver medicine and honorary consultant hepatologist1,
- Jessica Glen, senior research fellow2,
- Lefteris Floros, senior health economist2,
- Rachel Pryke, general practitioner partner3
- 1Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne NE2 4HH, UK
- 2National Guideline Centre, Royal College of Physicians, London NW1 4LE, UK
- 3Winyates Health Centre, Redditch B98 0NR, UK
- chris.day{at}ncl.ac.uk
In response to the letter from Tavabie,1 2 we chose the 10.51 cut-off for the enhanced liver fibrosis (ELF) test because of the higher quality of evidence available for this threshold than for two others (low quality versus very low …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £157 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£30 / $37 / €33 (excludes VAT)
You can download a PDF version for your personal record.